Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


11.08.2025

1 Ann Clin Lab Sci
1 Biomed Eng Online
1 Biomol Biomed
3 BMC Cancer
2 BMC Public Health
2 Brachytherapy
1 Cancer Causes Control
1 Cell Signal
1 Chem Biodivers
1 Comput Biol Chem
2 Cureus
1 Diagn Cytopathol
1 Discov Oncol
1 Epidemiol Serv Saude
1 Eur J Pharm Biopharm
4 Front Immunol
3 Front Oncol
1 Gynecol Oncol
1 Hereditas
1 Int J Behav Med
1 Int J Biol Macromol
1 Int J Radiat Oncol Biol Phys
1 J Cell Mol Med
1 J Cyst Fibros
1 J Educ Health Promot
1 J Inflamm Res
1 J Int Med Res
1 J Med Life
1 J Med Virol
1 J Pathol Clin Res
1 J Robot Surg
1 J Surg Case Rep
2 J Transl Med
1 JAMA Netw Open
1 JCO Clin Cancer Inform
2 Klin Onkol
3 Lancet
1 Medicine (Baltimore)
1 Microbiol Spectr
1 Nat Commun
1 NPJ Digit Med
1 Obstet Gynecol
1 Obstet Gynecol Clin North Am
1 Oncol Rep
1 Pathobiology
2 Photodiagnosis Photodyn Ther
1 Radiography (Lond)
1 Res Sq
1 Rev Bras Epidemiol
4 Sci Rep
1 Semin Reprod Med
2 Stud Health Technol Inform
1 Virol J


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Clin Lab Sci

  1. KRZESAJ PK, Seydafkan S, Miller AI, Chen HT, et al
    HDM-2-Targeting Peptide PNC-27 Kills Cervical Cancer Cells but not Normal Cervical Cells.
    Ann Clin Lab Sci. 2025;55:347-353.
    PubMed         Abstract available


    Biomed Eng Online

  2. LI M, Wu X, Liu X, Wen M, et al
    Effects of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) on survival benefits and poor prognostic factors in patients with cervical cancer.
    Biomed Eng Online. 2025;24:96.
    PubMed         Abstract available


    Biomol Biomed

  3. MATEEN AZHAR M, Maqbool T, Ali F, Altaf A, et al
    Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells.
    Biomol Biomed. 2025;25:1751-1764.
    PubMed         Abstract available


    BMC Cancer

  4. TUPA F, Ruwaichi T, Luoga P, Mwaiselage J, et al
    Institutional management factors influencing compliance with National Cancer Treatment Guidelines for cervical cancer: a case study from ocean road cancer institute, Tanzania.
    BMC Cancer. 2025;25:1259.
    PubMed         Abstract available

  5. ZHANG B, Li Z, Yang Z, Yin Y, et al
    Downregulation of PGK1 promotes lipid peroxidation and suppresses proliferation in cervical cancer revealed by liquid-liquid phase separation-related gene signature.
    BMC Cancer. 2025;25:1269.
    PubMed         Abstract available

  6. HAN S, Qin Y, He Y, Li M, et al
    LncRNA SNHG15 targets miR-200a-3p affects the proliferation, apoptosis, migration, and invasion of cervical cancer cells.
    BMC Cancer. 2025;25:1279.
    PubMed         Abstract available


    BMC Public Health

  7. GULLE BT, Tozduman B, Oren Celik MM
    Determinants of cancer screening participation in Turkiye: a nationwide study of demographic, socioeconomic, and lifestyle factors.
    BMC Public Health. 2025;25:2637.
    PubMed         Abstract available

  8. MHANGO P, Kumitawa A, Malata MP, Tang JH, et al
    Acceptability, feasibility and appropriateness of integrating HPV self-sampling for cervical cancer screening into voluntary family planning services in Malawi.
    BMC Public Health. 2025;25:2615.
    PubMed         Abstract available


    Brachytherapy

  9. OKUMA K, Murakami N, Inaba K, Kashihara T, et al
    Gel spacer-assisted salvage brachytherapy for pelvic recurrence after definitive chemoradiotherapy in cervical cancer: A single-institution retrospective study.
    Brachytherapy. 2025 Aug 5:S1538-4721(25)00246.
    PubMed         Abstract available

  10. CHAN K, Ballantyne H, Liu ZA, Milosevic M, et al
    Intra-operative process efficiency for in-room MRI-guided combined intracavitary/interstitial brachytherapy for cervical cancer.
    Brachytherapy. 2025 Jul 31:S1538-4721(25)00124.
    PubMed         Abstract available


    Cancer Causes Control

  11. POCOBELLI G, Lykken J, Haas JS, Tiro J, et al
    Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems.
    Cancer Causes Control. 2025 Aug 6. doi: 10.1007/s10552-025-02039.
    PubMed         Abstract available


    Cell Signal

  12. WANG J, Zhang J, Wang T, Rong C, et al
    Notch signaling pathway in cervical cancer: From molecular mechanism to therapeutic potential.
    Cell Signal. 2025;135:112042.
    PubMed         Abstract available


    Chem Biodivers

  13. YANG M, Lu Y, Han L, He Z, et al
    A Novel Endophytic Fungus, Alternaria semiverrucosa, and Its Ethyl Acetate Extract Inhibit the Proliferation, Migration, and Invasion of Cervical Cancer Cells.
    Chem Biodivers. 2025 Aug 6:e00945. doi: 10.1002/cbdv.202500945.
    PubMed         Abstract available


    Comput Biol Chem

  14. CHAND T, Vaishanavaa P, Dubey AK, Misra G, et al
    Identification of hub genes as potential diagnostic biomarkers for cervical cancer: A bioinformatic approach.
    Comput Biol Chem. 2025;119:108605.
    PubMed         Abstract available


    Cureus

  15. WYER A, Louis M, Okunlola OI, Richardson R, et al
    Enterocutaneous Fistula: A Challenging Complication in Cervical Cancer Management.
    Cureus. 2025;17:e87475.
    PubMed         Abstract available

  16. CHARTIAN MS, Chellani G, Singh M, Dhankar N, et al
    Interobserver Variability and Comparison of Liquid-Based Cytology Versus Conventional Pap Smear for Cervical Cancer Screening in a High-Risk Population.
    Cureus. 2025;17:e87210.
    PubMed         Abstract available


    Diagn Cytopathol

  17. FAN R, Song S, Shi H, Zhang X, et al
    A Retrospective Analysis of 1151 Chinese Women With Atypical Glandular Cells: Impact of High-Risk Human Papilloma Virus Status and Age on Cervical and Endometrial Neoplasia Risk.
    Diagn Cytopathol. 2025 Jun 9. doi: 10.1002/dc.25495.
    PubMed         Abstract available


    Discov Oncol

  18. XIAO WQ, Lee DH, Kim H, Zhang HN, et al
    Ethyl beta-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.
    Discov Oncol. 2025;16:1498.
    PubMed         Abstract available


    Epidemiol Serv Saude

  19. SILVA GO, Braga YS, Reis IF, Alessio Junior LE, et al
    Cervical cancer mortality: descriptive study and time series analysis, Mato Grosso, 2013-2022.
    Epidemiol Serv Saude. 2025;34:e20240503.
    PubMed         Abstract available


    Eur J Pharm Biopharm

  20. ALVAREZ-QUEZADA OA, Espino-Nunez YE, Valencia-Gomez LE, Martel-Estrada SA, et al
    Controlled release of curcumin and gemcitabine from mucoadhesive chitosan-gelatin polymeric ovules: Cytotoxic effects on cervical cancer cells.
    Eur J Pharm Biopharm. 2025 Aug 1:114834. doi: 10.1016/j.ejpb.2025.114834.
    PubMed         Abstract available


    Front Immunol

  21. LI Y, Lin Z, Lin G, Zhao Z, et al
    Revolutionizing cervical cancer treatment: single-cell sequencing of TSPAN1+ tumor EPCs and immune checkpoints to assess drug sensitivity and optimize therapy.
    Front Immunol. 2025;16:1574174.
    PubMed         Abstract available

  22. CHEN MM, Zhang BQ, Luan YS, Sun GL, et al
    The diagnostic of PAX1 gene methylation in cervical lesions and its role in the triage of non-16/18 HR-HPV positive.
    Front Immunol. 2025;16:1634297.
    PubMed         Abstract available

  23. TAN X, Yang J, Li Y, Wan K, et al
    Development of Z(HPV16E7)- granzyme B immunoaffitoxin: dual mechanisms targeting hpv16-positive cervical cancer through epithelial-mesenchymal transition inhibition and cell death.
    Front Immunol. 2025;16:1616715.
    PubMed         Abstract available

  24. YIN B, Chen C, Huang B, Ding J, et al
    Oncogenic CMTM6 drives M2a macrophages formation and fuels cervical cancer progression.
    Front Immunol. 2025;16:1621816.
    PubMed         Abstract available


    Front Oncol

  25. FOLINO G, Zent I, Eason L, Murugan V, et al
    Temporal trends of cervical cancer demographics: a CDC WONDER database study.
    Front Oncol. 2025;15:1567305.
    PubMed         Abstract available

  26. SUN H, Wang H, Liu Y, Xu H, et al
    Comparison of the SureX((R)) HPV genotyping test with the Digene Hybrid Capture((R)) 2 test in cervical cancer screening.
    Front Oncol. 2025;15:1627935.
    PubMed         Abstract available

  27. TEIXEIRA AL, Dias F, Gil da Costa RM
    Editorial: Exploring HPV's role in genitourinary cancers beyond cervical cancer.
    Front Oncol. 2025;15:1658619.
    PubMed        


    Gynecol Oncol

  28. WANG Y, Jia Z, Jiao J, Yue X, et al
    Analysis of the use of prophylactic ureteral stents in preventing iatrogenic ureteral injury during radical hysterectomy for cervical Cancer.
    Gynecol Oncol. 2025;200:155-160.
    PubMed         Abstract available


    Hereditas

  29. YANG Y, Guo Z
    Prognostic value of Linc00662/miR-16-5p/FASN in cervical cancer and regulation of tumor progression.
    Hereditas. 2025;162:151.
    PubMed         Abstract available


    Int J Behav Med

  30. CHAN DNS, Choi KC, Lee PPK, So WKW, et al
    The Effects of Motivational Interviewing on Promoting Human Papillomavirus Vaccination Initiation and Completion Among South Asian Mother/Daughter Dyads: A Pilot Randomised Controlled Trial.
    Int J Behav Med. 2025;32:574-585.
    PubMed         Abstract available


    Int J Biol Macromol

  31. WANG H, Shang K, Tang K, Duan Z, et al
    Development of palmatine chloride-loaded chitosan nanoparticles for enhanced and safe cervical cancer therapy.
    Int J Biol Macromol. 2025 Aug 4:146579. doi: 10.1016/j.ijbiomac.2025.146579.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  32. HUANG W, Fang X, Ou X, Chen L, et al
    Postoperative Adjuvant Treatments for Cervical Cancer: A Network Meta-analysis.
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06039.
    PubMed         Abstract available


    J Cell Mol Med

  33. ZHONG L, Li J, Zhong J, Zhang Y, et al
    IFI16 Induced by p53 Activates the NF-kappaB Pathway to Counteract Cisplatin-Induced Apoptosis in Cervical Cancer Cells.
    J Cell Mol Med. 2025;29:e70728.
    PubMed         Abstract available


    J Cyst Fibros

  34. STEPHENSON AL, Sharpe I, Sykes J, Ma X, et al
    Primary care physician involvement increases likelihood of cancer screening in people with cystic fibrosis: A population-based study from Ontario, Canada.
    J Cyst Fibros. 2025;24:698-703.
    PubMed         Abstract available


    J Educ Health Promot

  35. CHADHA L, Sharma P, Bhide N, Arya I, et al
    Empowering perimenopausal women: A critical examination of opportunistic teaching on cervical cancer awareness.
    J Educ Health Promot. 2025;14:268.
    PubMed         Abstract available


    J Inflamm Res

  36. WANG J, Chen Z, Guan M, Ma Z, et al
    The Persistent Threat of Chronic Inflammation on the Mortality Among Cervical Cancer Survivors: A Mendelian Randomization and Machine Learning Analysis Using UK Biobank and Chinese Cohort Data.
    J Inflamm Res. 2025;18:10267-10282.
    PubMed         Abstract available


    J Int Med Res

  37. SUSETIATI DA, Pudjiati SR, Wirohadidjojo YW, Chandra LA, et al
    Effectiveness of Lactobacillus therapy in women with cervical human papillomavirus infection: A systematic review and meta-analysis.
    J Int Med Res. 2025;53:3000605251363006.
    PubMed         Abstract available


    J Med Life

  38. SAVELIEV GM, Varlas VN, Piron-Dumitrascu M, Suciu N, et al
    Prioritizing the risk of cervical cancer: findings from the SCCUT Multicentre Initiative.
    J Med Life. 2025;18:590-593.
    PubMed         Abstract available


    J Med Virol

  39. XU L, Ma C, Cuschieri K, Bonde J, et al
    Clinical Validation of the Venus HPV Full-Genotyping Assay for Cervical Cancer Screening in the VALGENT-4 Framework.
    J Med Virol. 2025;97:e70527.
    PubMed         Abstract available


    J Pathol Clin Res

  40. LI L, Yao M, Li L, Shi S, et al
    Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome-wide mutation analysis.
    J Pathol Clin Res. 2025;11:e70040.
    PubMed         Abstract available


    J Robot Surg

  41. PAZZAGLIA E, Pasquini P, Jamaer E, Traen K, et al
    Pioneering telesurgery in gynecology: the first European case of total hysterectomy.
    J Robot Surg. 2025;19:460.
    PubMed         Abstract available


    J Surg Case Rep

  42. SULEJMANI H, Vasilevski F, Krsteska B, Tanevska Zrmanovska A, et al
    Radiation-induced rectal leiomyosarcoma in a cervical cancer survivor: a case report.
    J Surg Case Rep. 2025;2025:rjaf609.
    PubMed         Abstract available


    J Transl Med

  43. TSEMENTZI D, Meador R, Eng T, Shelton J, et al
    Associations among HPV persistence, the vaginal microbiome, and cervical cancer recurrence.
    J Transl Med. 2025;23:858.
    PubMed         Abstract available

  44. CHEN S, Dai H, Hu S, Gao T, et al
    Novel triple-target panels utilizing methylation-sensitive restriction enzyme-based quantitative PCR for detecting advanced cervical precancers and cancers among high-risk HPV-positive women.
    J Transl Med. 2025;23:857.
    PubMed         Abstract available


    JAMA Netw Open

  45. AL-BITAR A, Kouli A, Janoud O, Harb A, et al
    Breast and Cervical Cancer Gaps in Displaced Lebanese Women in Syria.
    JAMA Netw Open. 2025;8:e2525652.
    PubMed         Abstract available


    JCO Clin Cancer Inform

  46. NGUYEN AM, Waldron-Corredor A, Liu FY, Yun X, et al
    Breast, Cervical, and Colorectal Cancer Screening Among New Jersey Medicaid Enrollees: 2017-2022.
    JCO Clin Cancer Inform. 2025;9:e2500055.
    PubMed         Abstract available


    Klin Onkol

  47. SOROKIN P, Kulikova S, Stepanyan A, Davtyan H, et al
    Total mesometrial resection for the treatment of cervical cancer - an exploratory study of feasibility, safety and oncological outcomes in developing countries.
    Klin Onkol. 2025;38:201-208.
    PubMed         Abstract available

  48. SOUMAROVA R, Havlik J
    Current complex treatment for cervical cancer.
    Klin Onkol. 2025;38:185-191.
    PubMed         Abstract available


    Lancet

  49. LIU T, Lu D, Wu X
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply.
    Lancet. 2025;406:446.
    PubMed        

  50. CHENG C
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial.
    Lancet. 2025;406:445.
    PubMed        

  51. HUANG L, We Y, Chen F
    Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial.
    Lancet. 2025;406:445-446.
    PubMed        


    Medicine (Baltimore)

  52. ZHANG X, Xu J
    Alveolar rhabdomyosarcoma of cervix: A case report.
    Medicine (Baltimore). 2025;104:e43675.
    PubMed         Abstract available


    Microbiol Spectr

  53. HUANG S, Gentil LG, Schmidt C, Cullum R, et al
    Comparative clinical performance of Alinity m HR HPV, cobas 4800 HPV, and cobas 6800 HPV for cervical cancer screening.
    Microbiol Spectr. 2025 Aug 6:e0058925. doi: 10.1128/spectrum.00589.
    PubMed         Abstract available


    Nat Commun

  54. BARRA MJ, Wilkinson AF, Ma AE, Goli K, et al
    One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique.
    Nat Commun. 2025;16:7295.
    PubMed         Abstract available


    NPJ Digit Med

  55. WANG W, Yang G, Liu Y, Wei L, et al
    Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center study.
    NPJ Digit Med. 2025;8:503.
    PubMed         Abstract available


    Obstet Gynecol

  56. LI R, Sun LF, Li RZ, Wang ZY, et al
    Incidence of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Cancer or Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2025 Aug 7. doi: 10.1097/AOG.0000000000006026.
    PubMed         Abstract available


    Obstet Gynecol Clin North Am

  57. DE LA PENA R, Peterson E
    Common Cancers in the Pregnant Patient.
    Obstet Gynecol Clin North Am. 2025;52:507-517.
    PubMed         Abstract available


    Oncol Rep

  58. LI X, Zhou M, Yu J, Yu S, et al
    Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review).
    Oncol Rep. 2025;54:131.
    PubMed         Abstract available


    Pathobiology

  59. AL HINAI F, Al Shamsi R, Al Husaini S, Al Rashdi A, et al
    The Role of Cytokeratin 7 and Cytokeratin 19 Immunohistochemistry in the Evaluation of Human Papillomavirus-Induced Cervical Squamous Precursor Epithelial Lesions.
    Pathobiology. 2025;92:216-223.
    PubMed         Abstract available


    Photodiagnosis Photodyn Ther

  60. LI J, Huang Y, Tao J, Yang H, et al
    Evaluation of topical photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) for cervical intraepithelial neoplasia with human papillomavirus (HPV) infection: a retrospective comparative study versus loop electrosurgical excision procedure (LEE
    Photodiagnosis Photodyn Ther. 2025;54:104697.
    PubMed         Abstract available

  61. CHEN R, Xu J, Ye C, Lu L, et al
    Efficacy of 5-aminolevulinic acid photodynamic therapy versus observation for cervical low-grade squamous intraepithelial lesion with type 3 transformation zone.
    Photodiagnosis Photodyn Ther. 2025;54:104679.
    PubMed         Abstract available


    Radiography (Lond)

  62. LOPEZ-UBEDA P, Martin-Noguerol T, Luna A
    Natural language processing evaluation of trends in cervical cancer incidence in radiology reports: A ten-year survey.
    Radiography (Lond). 2025 Aug 4:103117. doi: 10.1016/j.radi.2025.103117.
    PubMed         Abstract available


    Res Sq

  63. MANGA S, Yuanfan Y, Scarinci I, Nulah K, et al
    Comparing a "See-and-Treat" HPV-Based to VIA-Based Cervical Cancer Prevention Strategies Among Women Living with HIV in Cameroon: A Pilot Study.
    Res Sq [Preprint]. 2025 Jul 28:rs.3.rs-7097928. doi: 10.21203/rs.3.rs-7097928.
    PubMed         Abstract available


    Rev Bras Epidemiol

  64. LIMA BG, Barros MBA
    Prevalence and social inequalities in the use of cancer screening tests in Campinas, Brazil (ISACamp 2014/15).
    Rev Bras Epidemiol. 2025;28:e250043.
    PubMed         Abstract available


    Sci Rep

  65. LIANG X, Zeng XT, Hong ZL, Lin XY, et al
    Perfluorobutane CEUS for early-stage cervical lymphoma: diagnostic value of the postvascular phase starfield sign.
    Sci Rep. 2025;15:28486.
    PubMed         Abstract available

  66. YANG WJ, Lee SH, Kim YJ, Kim KG, et al
    Comparison of performance of cervical cancer grading based on acetowhite areas.
    Sci Rep. 2025;15:28258.
    PubMed         Abstract available

  67. SHI R, Qi W, Wang Z, Cai J, et al
    High-risk human papillomavirus genotype distribution and attribution to cervical lesions in a Shanxi Province screening population.
    Sci Rep. 2025;15:28217.
    PubMed         Abstract available

  68. DE SOUZA ATB, de Sousa Santos DL, Medeiros FS, de Carvalho KTC, et al
    Comparison of IL-10 gene promoter polymorphisms and haplotypes between high-grade squamous intraepithelial lesions or cervical cancer and negative cervical cytology.
    Sci Rep. 2025;15:28330.
    PubMed         Abstract available


    Semin Reprod Med

  69. SELLAMI I, Sais E, Souare F, Becquart C, et al
    Fertility Preservation in Women with Cervical Cancer.
    Semin Reprod Med. 2025 Aug 1. doi: 10.1055/s-0045-1810055.
    PubMed         Abstract available


    Stud Health Technol Inform

  70. CHUKWUEMEKA I, Sudeshna D, Yuting G, Swati R, et al
    Bridging AI, NLP, and Digital Health: A Bi-Directional Learning Experience at Emory University.
    Stud Health Technol Inform. 2025;329:1822-1823.
    PubMed         Abstract available

  71. TAJIRIAN T, Adams N, Nicolle J, DeLasa C, et al
    Digitally Empowered: Boosting Cervical and Breast Cancer Screening for Patients with Severe Mental Illness Through Smart EHR Solutions.
    Stud Health Technol Inform. 2025;329:367-370.
    PubMed         Abstract available


    Virol J

  72. JING Y, Chen J, Lin F, Huang X, et al
    Multiple high-risk human papillomavirus infections exacerbate cervical lesion risk: epidemiological evidence from suining, Sichuan.
    Virol J. 2025;22:268.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.